Discover what’s new with CathWorks and the CathWorks FFRangio™ System.
Stay up-to-date on what‘s new.
Sep 24, 2018
CathWorks FFRangio™ Trial Meets Primary Enpoint and Exceeds Performance Goals.
The journal Circulation published results from the CathWorks FFRangio™ FAST-FFR clinical trial in an article titled Accuracy of Fractional Flow Reserve Derived From Coronary Angiography.
Sep 12, 2018
CathWorks FFRangio™ System Clinical Review Featured in TCT 2018 Program.
The CathWorks FFRangio™ System will be featured in a TCT Lunch Presentation Theater Program held during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Diego.
Aug 29, 2018
FAST-FFR Pivotal Trial Added To TCT 2018 Late-Breaking Clinical Trial Program.
CathWorks announced that the FAST-FFR pivotal trial has been added to the late-breaking clinical science program during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Diego.
Aug 22, 2018
CathWorks FFRangio™ System files FDA 510(k) submission.
CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.
Aug 15, 2018
CathWorks Fast-FFR trial enrollment completed early.
CathWorks announced that its FAST-FFR trial is fully enrolled ahead of schedule. The trial is designed to evaluate efficacy of the CathWorks FFRangio™ System in terms of sensitivity and specificity when compared to conventional invasive Fractional Flow Reserve (FFR).
Jul 11, 2018
CathWorks receives CPT code for new wire-free, intraprocedural FFR measurements to optimize PCI therapy decisions.
CathWorks announced the approval of a new CPT code 0523T for non-invasive, 3D FFRangio™ enabled interpretation of possible atherosclerotic stenosis during coronary angiography interventions.
Come and meet the CathWorks team at our various events and learn how the CathWorks FFRangio™ System can help you and your patients.